Liver transplantation

Hospital Medicine

Volumn 64, Issue 4, 2003, Pages 200-204

  Nash, Kathryn L ^a   Gimson, Alexander E S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TSUKUBAENOLIDE;

BONE MARROW SUPPRESSION; CLINICAL TRIAL; CONFERENCE PAPER; DONOR; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; NEPHROTOXICITY; NEUROTOXICITY; ORGAN DONOR; PREDICTION; SIDE EFFECT; TREATMENT OUTCOME; GRAFT REJECTION; INFECTION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT DISEASE; REOPERATION; REVIEW;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INFECTION; LIVER TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; REOPERATION; TISSUE DONORS;

EID: 0038750713     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2003.64.4.1776     Document Type: Conference Paper

References (20)

1. Devlin J, O'Grady J (1999) Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut 45 (Suppl 6):VII-VI22
2. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10: 1-7
3. Dickson ER, Murtaugh PA, Wiesner RH et al (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103: 1893-901
4. European FK506 Multicentre Liver Study Group (1994) Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344: 423-8
5. European Liver Transplant Registry (2002) www.eltr.org
6. Faust TW (2000) Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Semin Liver Dis 20: 481-95
7. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B (2001) De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 7: S109-18
8. Gane EJ, Portmann BC, Naoumov NV et al (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815-20
9. Iwatsuki S, Starzl TE, Todo S et al (1988) Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 20: 498-504
10. Keefe EB (2001) Liver transplantation; current status and future prospects. Gastroenterology 120: 749-62
11. Neuberger J, James O (1999) Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 354: 1636-9
12. O'Grady JG, Alexander GJ, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439-45
13. Pereira SP, Williams R (1998) Limits to liver transplantation in the UK. Gut 42: 883-5
14. Perrillo R, Rakela J, Dienstag J et al (1999) Multicenter study of lamivudine therapy for hepatitis B after liver transplantation Lamivudine Transplant Group. Hepatology 29: 1581-6
15. Prieto M, Berenguer M, Rayon JM et al (1999) High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29: 250-6
16. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329: 1842-7
17. Schluger LK, Sheiner PA, Thung SN et al (1996) Severe recurrent cholestatic hepatitis C following ormotopic liver transplantation. Hepatology 23: 971-6
18. Stratta RJ, Shaefer MS, Cushing KA et al (1991) Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation 51: 90-7
19. Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77: 2217-22
20. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE (1991) Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13: 619-26